Dosimetric comparison between realistic ocular model and other models for COMS plaque brachytherapy with 103Pd, 131Cs, and 125I radioisotopes

被引:7
|
作者
Ebrahimi-Khankook, Atiyeh [1 ]
Vejdani-Noghreiyan, Alireza [1 ]
机构
[1] Univ Neyshabur, Fac Sci, Phys Dept, Neyshabur, Iran
关键词
Realistic eye model; MCNP code; Brachytherapy; Dosimetry; DOSE CONVERSION COEFFICIENTS; HUMAN EYE MODEL; INTRAOCULAR TUMORS; INCIDENT; IMPLANT; AAPM; LENS;
D O I
10.1007/s00411-018-0748-3
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nowadays, Monte Carlo calculations are commonly used for the evaluation of dose distributions and dose volume histograms in eye brachytherapy. However, currently available eye models have simple geometries, and main substructures of the eye are either not defined in details or not distinguished at all. In this work absorbed doses of eye substructures have been estimated for eye plaque brachytherapy using the most realistic eye model available, and compared with absorbed doses obtained with other available eye models. For this, a medium-sized tumour on the left sides of the right eye was considered. Dosimetry calculations were performed for four different eye models developed based on a literature review, and using a 12 mm Collaborative Ocular Melanoma Study plaque containing Cs-131, Pd-103, and I-125 sources. Obtained results illustrate that the estimated doses received by different eye substructures strongly depend on the model used to represent the eye. It is shown here that using a non-realistic eye model leads to a wrong estimation of doses for some eye substructures. For example, dose differences of up to 35% were observed between the models proposed by Nogueira and co-workers and Yoriyaz and co-workers, while doses obtained by use of the models proposed by Lesperance and co-workers, and Behrens and co-workers differed up to 100 and 63% as compared to the situation when a realistic model was used, respectively. Moreover, comparing different radionuclides showed that the most uniform dose distribution in the considered tumour region was that from Cs-131, with a coefficient of variation of 33%. In addition, considering the realistic eye model, it was found that the radiosensitive region of the lens received more than the threshold dose of cataract induction (0.5 Gy), for all investigated radionuclides.
引用
收藏
页码:265 / 275
页数:11
相关论文
共 18 条
  • [1] Dosimetric comparison between realistic ocular model and other models for COMS plaque brachytherapy with 103Pd, 131Cs, and 125I radioisotopes
    Atiyeh Ebrahimi-Khankook
    Alireza Vejdani-Noghreiyan
    Radiation and Environmental Biophysics, 2018, 57 : 265 - 275
  • [2] COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs
    Melhus, Christopher S.
    Rivard, Mark J.
    MEDICAL PHYSICS, 2008, 35 (07) : 3364 - 3371
  • [3] A comprehensive dosimetric comparison between 131Cs and 125I brachytherapy sources for COMS eye plaque implant
    Zhang, Hualin
    Martin, Douglas
    Chiu-Tsao, Sou-Tung
    Meigooni, Ali
    Thomadsen, Bruce R.
    BRACHYTHERAPY, 2010, 9 (04) : 362 - 372
  • [4] Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom
    Lesperance, Marielle
    Martinov, M.
    Thomson, R. M.
    MEDICAL PHYSICS, 2014, 41 (03)
  • [5] Comparison between dose distribution from 103Pd, 131Cs, and 125I plaques in a real human eye model with different tumor size
    Taherparvar, Payvand
    Fardi, Zeinab
    APPLIED RADIATION AND ISOTOPES, 2022, 182
  • [6] Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy
    Thomson, R. M.
    Taylor, R. E. P.
    Rogers, D. W. O.
    MEDICAL PHYSICS, 2008, 35 (12) : 5530 - 5543
  • [7] Dosimetric and radiobiologic comparison of 103Pd COMS plaque brachytherapy and Gamma Knife radiosurgery for choroidal melanoma
    Gorovets, Daniel
    Gagne, Nolan L.
    Melhus, Christopher S.
    BRACHYTHERAPY, 2017, 16 (02) : 433 - 443
  • [8] A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using 125I, 103Pd, and 131Cs and historical perspective
    Leonard, Kara L.
    Gagne, Nolan L.
    Mignano, John E.
    Duker, Jay S.
    Bannon, Elizabeth A.
    Rivard, Mark J.
    BRACHYTHERAPY, 2011, 10 (04) : 331 - 339
  • [9] The impact of prescription depth, dose rate, plaque size, and source loading on the central axis using 103Pd, 125I, and 131Cs
    Rivard, Mark J.
    Melhus, Christopher S.
    Sioshansi, Shirin
    Morr, Jody
    BRACHYTHERAPY, 2008, 7 (04) : 327 - 335
  • [10] Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models
    Thomson, R. M.
    Rogers, D. W. O.
    MEDICAL PHYSICS, 2010, 37 (01) : 368 - 376